No Data
AI technology is reshaping the healthcare industry, with the AI healthcare sector experiencing an extended rise.
As the global artificial intelligence boom continues to gain momentum, capital markets have significantly increased their attention on the AI healthcare sector. The AI healthcare segment has also attracted substantial investment inflows, with related stocks collectively surging today.
Fangzhou Says Unaware of Reason for Share Price Movement; Shares Slip 6%
At the 'Pharma Spring Festival Gala,' NVIDIA elaborated on 'How to Advance AI in Healthcare.'
JPMorgan stated that NVIDIA is implementing a "full-stack" layout in AI healthcare, constructing a closed loop from chips to tools and then to domain-specific models, known as the "dry lab - wet lab" flywheel. Meanwhile, AI is transitioning from "pilot" to "deployment," with the speed of commercial AI adoption in the U.S. healthcare industry being three times that of the overall economy. At the physical laboratory level, NVIDIA is collaborating with Thermo Fisher Scientific, further accelerating the industrialization process of drug discovery.
The strategic cooperation between Ark Jianke (06086) and Tencent Health is part of the group's regular and general business operations.
Fangzhou Jianke (06086) announced that the company's board of directors (the Board) has noted recent news reports regarding the strategic cooperation between the group and Tencent Health announced earlier. After conducting reasonable inquiries under the relevant circumstances, the company confirmed that the cooperation was carried out in the ordinary and normal course of business of the group. After making relevant inquiries about the company, the Board confirmed that it is not aware of any underlying reasons for the increase in the trading price of the company’s shares or any information that needs to be disclosed to avoid creating a false market for the company’s securities. Additionally, there is no insider information that requires disclosure under Rule 13.09(2) of the Listing Rules and Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).
Hong Kong Stocks Close (01.13) | Hang Seng Index Rises 0.9%, Commercial Spaceflight Concept Cools, Pharmaceuticals and Gold Stocks Perform Strongly
Hong Kong stocks surged before retreating today, with the Hang Seng Index briefly breaking through 27,000 points in the morning session, while the Hang Seng Tech Index temporarily turned negative in the afternoon.
Hong Kong Stock Market Midday Review | Hang Seng Index rose 1.01% in the morning session, with CRO concept stocks leading the gains.
CRO concept stocks are among the top gainers. Wuxi Apptec (02359) expects its net profit last year to double, and the sector is anticipated to experience a 'Davies Double.'